Nanoporous biomimetic vector to maximise the therapeutic efficacy of proteasome inhibitors


Mesoporous silica nanoparticle (SM) + drug molecules + double lipidic layer coating (DLS) with PEGylated lipids (PEG) and conjugated to monoclonal antibodies (mAb) for targeting

This project has received funding from the POC INSTRUMENT 2019